No Data
No Data
Shaanxi Meibang Pharmaceutical Group to Terminate Bond Issue
Meibang Stock(605033.SH): Terminate the issuance of convertible corporate bonds to unspecified objects and withdraw the application documents.
Gelonghui November 13th | Meiban shares (605033.SH) announced that since the company applied to issue convertible corporate bonds to unspecified objects, the company has actively promoted related work with relevant institutions. However, considering factors such as operational performance and market environment, the company has repeatedly communicated prudently with various intermediary institutions and decided to terminate the issuance of convertible corporate bonds to unspecified objects this time.
Shaanxi Meibang Pharmaceutical Group's (SHSE:605033) Shareholders Have More To Worry About Than Only Soft Earnings
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024
Announcement of major operating data for the third quarter of 2024 of Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Meibang Shares (605033.SH): net income in the first three quarters was 43.276 million yuan, a year-on-year decrease of 38.34%.
GeLongHui on October 29th: Meibang Stock(605033.SH) released its third-quarter report, with a revenue of 0.62 billion yuan in the first three quarters, a year-on-year increase of 12.49%, a net income of 43.276 million yuan, a year-on-year decrease of 38.34%, a non-net profit of 31.37 million yuan, a year-on-year decrease of 52.62%, and an EPS of 0.32 yuan.
No Data
No Data